AMNEAL PHARMACEUTICALS INC (AMRX) Stock Cash Flow
NASDAQ:AMRX - Nasdaq - US03168L1052 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -536.00K | -73.88M | -48.72M | -254.79M | 20.17M | |||
| Depreciation Amortization | 66.95M | 236.19M | 229.40M | 240.18M | 233.41M | |||
| Income Taxes - Deferred | N/A | N/A | N/A | N/A | 0.00 | |||
| Change In Working Capital | -63.26M | -4.07M | -47.19M | -59.95M | -133.59M | |||
| Interest Paid | 127.03M | 263.52M | 192.81M | 142.72M | 121.75M | |||
| Taxes Paid | 21.33M | 15.22M | -2.50M | -12.65M | -15.56M | |||
| Other non cash items | -46.22M | 136.85M | 212.09M | 139.66M | 121.84M | |||
| OPERATING CASH FLOW | -43.07M | 295.10M | 345.58M | 65.10M | 241.82M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -24.12M | -74.99M | -69.19M | -90.59M | -52.64M | |||
| Other Investing Activity | N/A | 11.99M | 0.00 | -83.71M | -141.54M | |||
| INVESTING CASH FLOW | -11.61M | -63.00M | -69.19M | -174.31M | -194.18M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -225.30M | -185.12M | 22.65M | -38.27M | -79.18M | |||
| Stock Issued/Repurchased | 772.00K | 1.15M | 451.00K | 662.00K | 853.00K | |||
| Dividend Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other Financing Activity | 186.14M | -27.83M | -235.68M | -69.01M | -59.80M | |||
| FINANCING CASH FLOW | -38.38M | -211.79M | -212.57M | -106.62M | -138.12M | |||
| Exchange Rate Effect | -1.53M | -999.00K | 65.00K | -5.68M | 102.00K | |||
| CHANGE IN CASH | -94.59M | 19.31M | 63.88M | -221.51M | -90.38M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -43.07M | 295.10M | 345.58M | 65.10M | 241.82M | |||
| Capital Expenditure | -24.12M | -74.99M | -69.19M | -90.59M | -52.64M | |||
| FREE CASH FLOW | -67.19M | 220.11M | 276.39M | -25.50M | 189.18M | |||
All data in USD